KURA ONCOLOGY INC's ticker is and the CUSIP is 50127T909. A total of 3 filers reported holding KURA ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11 | +450.0% | 1,300 | +550.0% | 0.00% | – |
| Q1 2023 | $2 | -97.5% | 200 | -96.9% | 0.00% | – |
| Q4 2022 | $79 | -100.0% | 6,400 | -66.8% | 0.00% | – |
| Q3 2022 | $263,000 | +2822.2% | 19,300 | +3760.0% | 0.00% | – |
| Q2 2022 | $9,000 | +12.5% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -96.3% | 500 | -96.7% | 0.00% | – |
| Q4 2021 | $214,000 | -58.2% | 15,300 | -35.2% | 0.00% | – |
| Q3 2021 | $512,000 | +4.1% | 23,600 | 0.0% | 0.00% | – |
| Q2 2021 | $492,000 | +123.6% | 23,600 | +30156.4% | 0.00% | – |
| Q1 2021 | $220,000 | -65.6% | 78 | -60.2% | 0.00% | -100.0% |
| Q4 2020 | $640,000 | -48.4% | 196 | -51.6% | 0.00% | -50.0% |
| Q3 2020 | $1,240,000 | +29.8% | 405 | -30.9% | 0.00% | 0.0% |
| Q2 2020 | $955,000 | +2628.6% | 586 | +1527.8% | 0.00% | – |
| Q1 2020 | $35,000 | -37.5% | 36 | -12.2% | 0.00% | – |
| Q4 2019 | $56,000 | +40.0% | 41 | +51.9% | 0.00% | – |
| Q3 2019 | $40,000 | +110.5% | 27 | +170.0% | 0.00% | – |
| Q2 2019 | $19,000 | +1800.0% | 10 | +900.0% | 0.00% | – |
| Q1 2019 | $1,000 | -94.7% | 1 | -92.9% | 0.00% | – |
| Q4 2018 | $19,000 | -20.8% | 14 | 0.0% | 0.00% | – |
| Q3 2018 | $24,000 | +2300.0% | 14 | +1300.0% | 0.00% | – |
| Q2 2018 | $1,000 | -88.9% | 1 | -93.3% | 0.00% | – |
| Q1 2018 | $9,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 45,400 | $636,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 15,300 | $214,000 | 0.00% |